Hove Anders D
Insider CIK 1365618 · WHRT Director, 10% owner · ANAC Director, 10% owner · IRWD 10% owner · EDGE Director · AAVL 10% owner · INSP 10% owner · OKUR 10% owner · ABIO Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OKUR OnKure Therapeutics, Inc. | P Buy | 2025-05-15 | 2025-05-19 | 270,270 | $1.85 | $500.0K | 1,709,944 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | P Buy | 2025-05-15 | 2025-05-19 | 1,129,730 | $1.85 | $2.09M | 1,129,730 | SEC↗ |
| ABIO ARCA biopharma, Inc. | A Award deriv | 2024-01-30 | 2024-01-31 | 6,000 | — | $0 | 6,000 | SEC↗ |
| ABIO ARCA biopharma, Inc. | A Award deriv | 2022-12-15 | 2022-12-19 | 6,000 | — | $0 | 6,000 | SEC↗ |
| ABIO ARCA biopharma, Inc. | A Award deriv | 2021-01-12 | 2021-01-13 | 12,000 | — | $0 | 12,000 | SEC↗ |
| INSP Inspire Medical Systems, I | C Conversion deriv | 2018-05-07 | 2018-05-09 | 9,124,088 | — | $0 | 0 | SEC↗ |
| INSP Inspire Medical Systems, I | P Buy | 2018-05-07 | 2018-05-09 | 125,000 | $16.00 | $2.00M | 1,497,043 | SEC↗ |
| INSP Inspire Medical Systems, I | C Conversion | 2018-05-07 | 2018-05-09 | 1,372,043 | — | $0 | 1,372,043 | SEC↗ |
| ABIO ARCA biopharma, Inc. | A Award deriv | 2018-03-01 | 2018-03-05 | 8,000 | — | $0 | 8,000 | SEC↗ |
| ABIO ARCA biopharma, Inc. | A Award deriv | 2017-02-16 | 2017-02-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | D To issuer deriv | 2016-06-24 | 2016-06-24 | 12,500 | — | $0 | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | D To issuer deriv | 2016-06-24 | 2016-06-24 | 15,000 | — | $0 | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | D To issuer deriv | 2016-06-24 | 2016-06-24 | 30,000 | — | $0 | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | D To issuer deriv | 2016-06-24 | 2016-06-24 | 4,096 | — | $0 | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | D To issuer deriv | 2016-06-24 | 2016-06-24 | 15,000 | — | $0 | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | D To issuer deriv | 2016-06-24 | 2016-06-24 | 15,000 | — | $0 | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | D To issuer | 2016-06-24 | 2016-06-24 | 33,886 | $99.25 | $3.36M | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2016-05-16 | 2016-05-18 | 81,631 | $100.60 | $8.21M | 272,250 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2016-05-16 | 2016-05-18 | 72,385 | $98.93 | $7.16M | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2016-05-16 | 2016-05-18 | 199,865 | $99.41 | $19.87M | 72,385 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | C Conversion deriv | 2016-04-14 | 2016-04-15 | 0 | — | $0 | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | C Conversion | 2016-04-14 | 2016-04-15 | 257,647 | $31.05 | $8.00M | 353,881 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2016-04-08 | 2016-04-11 | 400 | $71.40 | $28.6K | 96,234 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2016-04-08 | 2016-04-11 | 3,868 | $70.05 | $271.0K | 96,634 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2016-04-07 | 2016-04-11 | 13,000 | $72.15 | $938.0K | 109,794 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2016-04-07 | 2016-04-11 | 6,820 | $75.57 | $515.4K | 100,502 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2016-04-07 | 2016-04-11 | 200 | $74.13 | $14.8K | 107,322 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2016-04-07 | 2016-04-11 | 2,272 | $73.29 | $166.5K | 107,522 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2016-04-07 | 2016-04-11 | 99,981 | $71.44 | $7.14M | 122,794 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2016-04-07 | 2016-04-11 | 102,760 | $70.33 | $7.23M | 222,775 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2015-12-15 | 2015-12-17 | 900,000 | $111.25 | $100.13M | 325,535 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2015-12-11 | 2015-12-15 | 40,000 | $117.36 | $4.69M | 33,886 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2015-11-10 | 2015-11-12 | 100,295 | $103.60 | $10.39M | 1,598,517 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | J Other | 2015-11-10 | 2015-11-12 | 73,092 | — | $0 | 73,886 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | J Other | 2015-11-10 | 2015-11-12 | 372,982 | — | $0 | 1,225,535 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | J Other | 2015-11-03 | 2015-11-05 | 1,500,000 | — | $0 | 1,225,535 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | J Other | 2015-11-03 | 2015-11-05 | 372,982 | — | $0 | 1,598,517 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | J Other | 2015-11-03 | 2015-11-12 | 372,982 | — | $0 | 1,698,812 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | J Other | 2015-11-03 | 2015-11-12 | 1,399,705 | — | $0 | 1,325,830 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | C Conversion deriv | 2015-10-06 | 2015-10-08 | 2,150,538 | — | $0 | 0 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | J Other | 2015-10-06 | 2015-10-08 | 46,665 | $8.60 | $401.3K | 2,068,582 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | P Buy | 2015-10-06 | 2015-10-08 | 450,000 | $11.00 | $4.95M | 2,021,917 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | C Conversion | 2015-10-06 | 2015-10-08 | 1,571,917 | — | $0 | 1,571,917 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award deriv | 2015-06-09 | 2015-06-11 | 4,096 | — | $0 | 4,096 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award | 2015-06-09 | 2015-06-11 | 794 | — | $0 | 794 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award deriv | 2014-10-16 | 2014-10-20 | 0 | $8000000.00 | $0 | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award deriv | 2014-10-16 | 2014-10-21 | 0 | $8000000.00 | $0 | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2014-09-26 | 2014-09-30 | 20,000 | $25.00 | $500.0K | 2,725,535 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2014-09-19 | 2014-09-22 | 738,500 | $24.87 | $18.37M | 2,745,535 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2014-09-18 | 2014-09-22 | 1,500 | $24.87 | $37.3K | 3,484,035 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2014-09-16 | 2014-09-16 | 75,000 | $24.99 | $1.87M | 3,485,535 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2014-09-12 | 2014-09-16 | 15,000 | $24.98 | $374.7K | 3,560,535 | SEC↗ |
| AAVL Avalanche Biotechnologies, | C Conversion deriv | 2014-08-05 | 2014-08-07 | 1,965,471 | — | $0 | 0 | SEC↗ |
| AAVL Avalanche Biotechnologies, | C Conversion | 2014-08-05 | 2014-08-07 | 1,965,471 | — | $0 | 1,965,471 | SEC↗ |
| AAVL Avalanche Biotechnologies, | P Buy | 2014-08-05 | 2014-08-07 | 400,000 | $17.00 | $6.80M | 2,365,471 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award deriv | 2014-05-29 | 2014-06-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2013-11-15 | 2013-11-19 | 150,000 | $14.06 | $2.11M | 3,575,535 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award deriv | 2013-06-06 | 2013-06-10 | 15,000 | — | $0 | 15,000 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | J Other | 2013-03-15 | 2013-03-19 | 504,255 | — | $0 | 1,512,766 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | J Other | 2013-03-15 | 2013-03-19 | 7,483 | — | $0 | 7,483 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | J Other | 2013-03-15 | 2013-03-19 | 95,745 | — | $0 | 287,234 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | J Other | 2013-03-15 | 2013-03-19 | 18,910 | — | $0 | 18,910 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | J Other | 2013-03-15 | 2013-03-19 | 88,262 | — | $0 | 88,262 | SEC↗ |
| ANAC Anacor Pharmaceuticals Inc | S Sale | 2012-09-20 | 2012-09-24 | 19,273 | $6.30 | $121.4K | 3,725,535 | SEC↗ |
| ANAC Anacor Pharmaceuticals Inc | S Sale | 2012-09-14 | 2012-09-18 | 35,000 | $6.51 | $227.8K | 3,744,808 | SEC↗ |
| ANAC Anacor Pharmaceuticals Inc | S Sale | 2012-09-13 | 2012-09-13 | 15,000 | $6.56 | $98.4K | 3,779,808 | SEC↗ |
| ANAC Anacor Pharmaceuticals Inc | S Sale | 2012-09-11 | 2012-09-13 | 10,177 | $6.64 | $67.6K | 3,794,808 | SEC↗ |
| WHRT WORLD HEART CORP | D To issuer deriv | 2012-08-02 | 2012-08-06 | 2,107,728 | $0.10 | $210.8K | 0 | SEC↗ |
| WHRT WORLD HEART CORP | D To issuer | 2012-08-02 | 2012-08-06 | 6,162,744 | — | $0 | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals Inc | J Other | 2012-07-02 | 2012-07-05 | 900,000 | — | $0 | 3,725,535 | SEC↗ |
| ANAC Anacor Pharmaceuticals Inc | J Other | 2012-07-02 | 2012-07-05 | 79,450 | — | $0 | 3,804,985 | SEC↗ |
| ANAC Anacor Pharmaceuticals Inc | A Award deriv | 2012-05-30 | 2012-05-31 | 12,500 | — | $0 | 12,500 | SEC↗ |